AMD Ryzen 4000 “Vermeer” could launch in September

Published: Apr 9th 2020, 07:30 GMT   Comments

AMD Zen3 for desktop expected in September

Tom’s Hardware is reporting after DigiTimes that AMD is planning to launch Ryzen 4000 series for desktop around September. This rumored launch collides with a new date for Computex expo, which has now shifted to September 28. Thus, AMD could be showing new processor series at the event, a report from ComputerBase indicates.

There are some rumors that AMD was originally planning to launch Ryzen 4000 at Computex in June, but ComputerBase sources confirm that was never the case. The series was not expected sooner than July.

In fact, AMD Lisa Su already confirmed in an interview that Zen 3 desktop will launch the end of this year. She reiterated this claim during Analyst Day in March.

AMD Ryzen 4000 series, codenamed Vermeer, will feature Zen 3 architecture with further 7nm node optimizations. If the rumors are true, then the desktop 4000 series will arrive half a year later after the recently announced mobile 4000 series (based on Zen 2).

Source: DigiTimes (paywall) via Tom’s Hardware, ComputerBase




Comment Policy
  1. Comments must be written in English.
  2. Comments must not exceed 1000 characters. Comment splitting is not allowed.
  3. Comments deemed to be spam or solely promotional in nature will be deleted.
  4. Discussions about politics are not allowed on this website.
  5. Sharing relevant links is permitted; avoid bypassing the link and word filters. Our team will approve links.
  6. Comments complaining about the post subject or its source will be removed.
  7. Offensive language in comments or usernames result in a ban.
  8. Direct attacks/harassment result in immediate ban.
  9. VideoCardz isn’t and was never sponsored by AMD, Intel, or NVIDIA. Users claiming otherwise will be banned.
  10. Moderators may edit/delete comments without notice.
  11. If you have any questions about the commenting policy, please let us know through the Contact Page.
Hide Comment Policy
Comments